Max Neeman International
Headquartered in New Delhi, India, Max Neeman International is an ISO certified Contract Research Organization with the expertise to assist pharmaceutical, biotech and device industry in all aspects of conducting clinical trials in India and worldwide.

As the clinical research division of healthcare consortium ‘Max India’, Max Neeman International has the backing of this $1 billion life sciences consortium, owning twelve hospitals and managing other healthcare businesses in life insurance, healthcare and clinical research.

Highlights

• Full service CRO with focus on Phase I to IV clinical trials for drugs, pilot and pivotal medical device studies
• 90% of employees are Physicians (MDs) and ICH GCP trained (Clinical Research Coordinators/Project Managers/ Clinical Research Associates)
• Offices strategically placed across cities throughout India, increasing recruitment, sustaining hospital relationships, and attracting top talent
• 175 active sites in 22 cities, maintained relationships with 800 ICH GCP trained Investigators and a patient pool of 8–10 million
• Data from multiple global trials included for U.S. NDA approval from pivotal Phase III studies
• Ongoing clinical services to 8 of the top 10 global pharmaceuticals plus biotechnology firms
• Certification: ISO 9001:2008 certified by United Kingdom Accreditation Service (UKAS) for Site Management, Monitoring and Data Management
• Certification: ISO 27001 certification for ISMS (Information Security Management System) under process
• Partnerships with USA and Europe based clinical research organizations for global trials
• Partnerships with numerous CAP accredited central labs throughout India

• Established Practice and Site Management services began in 2001
• First U.S. FDA GCP audit occurred and Monitoring services were initiated in 2005
• Data Management Centre was set up and operations began in 2006
• 170th trial awarded in 2009, across 8 of 10 top U.S. Pharmas and numerous Biotechs; 50th clinical trial awarded in 2007 and ISO 9001:2000 certifi cation achieved
• Four successful FDA audits, combined with forty sponsor, regulatory body audits and multiple site audits, to date

For further information you may please visit:

www.neeman-medical.com